Unique ID issued by UMIN | UMIN000038249 |
---|---|
Receipt number | R000043583 |
Scientific Title | Evaluation of the efficacy of test food on blood flow improvement |
Date of disclosure of the study information | 2019/10/20 |
Last modified on | 2020/10/09 10:27:27 |
Evaluation of the efficacy of test food on blood flow improvement
Evaluation of the efficacy of test food on blood flow improvement
Evaluation of the efficacy of test food on blood flow improvement
Evaluation of the efficacy of test food on blood flow improvement
Japan |
Healthy adults
Adult |
Others
NO
To evaluate the efficacy of single-consumption of the test food on blood flow improvement.
Efficacy
Blood flow
Skin surface temperature
Core body temperature
VAS for feeling of cold
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Prevention
Food |
Taking a placebo food -> Washout period for over 1 week -> Taking a test food 1 -> Washout period for over 1 week -> Taking a test food 2
Taking a test food 1 -> Washout period for over 1 week -> Taking a test food 2 -> Washout period for over 1 week -> Taking a placebo food
Taking a test food 2 -> Washout period for over 1 week -> Taking a placebo food -> Washout period for over 1 week -> Taking a test food 1
20 | years-old | <= |
65 | years-old | >= |
Male and Female
1) Healthy males and females from 20 to 64 years old.
2) Subjects who are sensitive to cold.
3) Subjects whose written informed consent has been obtained.
1) Subjects who were diagnosed as oversensitiveness to cold by medical doctor.
2) Subjects who are undergoing some kind of drug treatment.
3) Subjects who constantly use oral medicines, functional foods or supplements which improve fatigue, blood flow, coldness or stress.
4) Females who are pregnant or lactating, and who could become pregnant during test period.
5) Subjects who have current or previous medical history of serious disease.
6) Subjects who consume excessive alcohol.
7) Smoker.
8) Subjects who have extremely irregular habits of dining, and who have irregular lifestyle rhythms.
9) Subjects who have allergy to drug or food.
10) Subjects who have cold allergy.
11) Subjects who are participating the other clinical tests. Subjects who participated within 4-weeks prior to the current study or who plan to participate the other clinical tests.
12) Subjects who have been determined ineligible by principal investigator or sub-investigator.
12
1st name | Shukuko |
Middle name | |
Last name | Ebihara |
Chiyoda Paramedical Care Clinic
Director
101-0047
2F Sanwauchikanda Building , 3-3-5 Uchikanda Chiyoda-ku, Tokyo, Japan
03-5297-5548
cpcc-contact@cpcc.co.jp
1st name | Mitsuhiro |
Middle name | |
Last name | Fujimoto |
CPCC Company Limited
Planning & Sales Department
101-0047
4F Sanwauchikanda Building , 3-3-5 Uchikanda Chiyoda-ku, Tokyo, Japan
03-5297-3112
cpcc-contact@cpcc.co.jp
CPCC Company Limited
KOBAYASHI Pharmaceutical Co., Ltd.
Profit organization
Institutional Review Board of Chiyoda Paramedical Care Clinic
2F Sanwauchikanda Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, Japan
03-5297-5548
IRB@cpcc.co.jp
NO
2019 | Year | 10 | Month | 20 | Day |
Unpublished
Completed
2019 | Year | 09 | Month | 24 | Day |
2019 | Year | 09 | Month | 20 | Day |
2019 | Year | 10 | Month | 21 | Day |
2019 | Year | 12 | Month | 03 | Day |
2019 | Year | 10 | Month | 09 | Day |
2020 | Year | 10 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043583